— Know what they know.
Not Investment Advice
Also trades as: 0QK8.L (LSE) · $vol 0M · BTL.DE (XETRA) · $vol 0M · BAX.SW (SIX)

BAX NYSE

Baxter International Inc.
1W: +7.0% 1M: +3.9% 3M: -11.8% YTD: -2.4% 1Y: -38.7% 3Y: -52.6% 5Y: -74.8%
$19.18
+0.15 (+0.79%)
 
Weekly Expected Move ±6.0%
$15 $16 $17 $18 $19
NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 59 · $9.9B mcap · 512M float · 1.69% daily turnover · Short 72% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -1.7%  ·  5Y Avg: -0.0%
Cost Advantage ★
57
Intangibles
25
Switching Cost
21
Network Effect
30
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BAX has No discernible competitive edge (34.9/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -1.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$27
Low
$27
Avg Target
$27
High
Based on 1 analyst since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 20Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$27.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-04 Barclays $25 $27 +2 +56.9% $17.21
2026-02-17 Goldman Sachs $23 $17 -6 -17.2% $20.54
2026-02-16 UBS Danielle Antalffy $24 $19 -5 -4.0% $19.79
2026-02-13 Deutsche Bank Initiated $20 +4.0% $19.23
2026-02-13 Barclays $30 $25 -5 +33.6% $18.71
2026-02-12 Jefferies $42 $19 -23 +1.5% $18.71
2026-02-12 Stifel Nicolaus $22 $20 -2 +6.9% $18.71
2026-01-09 Barclays Matt Miksic $36 $30 -6 +45.0% $20.69
2026-01-09 Goldman Sachs $22 $23 +1 +11.2% $20.69
2026-01-05 Evercore ISI Vijay Kumar $42 $23 -19 +14.9% $20.02
2025-12-02 Morgan Stanley Patrick Wood $30 $15 -15 -21.4% $19.08
2025-10-31 Goldman Sachs David Roman $36 $22 -14 +17.0% $18.81
2025-10-30 Stifel Nicolaus $44 $22 -22 +14.7% $19.18
2025-08-04 Barclays $54 $36 -18 +60.4% $22.44
2025-08-04 UBS $40 $24 -16 +7.0% $22.44
2025-01-02 Evercore ISI Vijay Kumar Initiated $42 +43.5% $29.26
2024-10-04 Bank of America Securities Travis Steed $100 $45 -55 +23.9% $36.32
2024-08-06 Jefferies Matthew Taylor $43 $42 -1 +13.8% $36.92
2024-07-15 Morgan Stanley Patrick Wood $105 $30 -75 -15.1% $35.32
2024-06-12 Goldman Sachs David Roman $91 $36 -55 +8.1% $33.31
2024-05-03 UBS Danielle Antalffy Initiated $40 +8.4% $36.91
2024-05-02 Jefferies Matthew Taylor $85 $43 -42 +16.6% $36.89
2024-05-02 Stifel Nicolaus Rick Wise Initiated $44 +19.8% $36.73
2023-07-31 Barclays Matt Miksic Initiated $54 +19.3% $45.26
2023-07-31 Jefferies Philippe Houchois Initiated $85 +80.8% $47.01
2023-03-27 Citigroup Joanne Wuensch $101 $44 -57 +10.8% $39.71
2022-04-29 Raymond James Initiated $85 +20.8% $70.35
2022-04-29 Wells Fargo Initiated $90 +28.2% $70.20
2022-03-02 Bank of America Securities Travis Steed Initiated $100 +17.4% $85.19
2022-02-17 Morgan Stanley David Lewis Initiated $105 +27.5% $82.35
2022-02-12 Goldman Sachs Amit Hazan Initiated $91 +5.9% $85.91
2022-01-06 Citigroup Joanne Wuensch Initiated $101 +15.9% $87.16
2021-12-16 J.P. Morgan Robbie Marcus Initiated $95 +14.0% $83.36
2021-12-12 Cowen & Co. Josh Jennings Initiated $98 +18.2% $82.93
2021-09-01 Piper Sandler Matthew O'Brien Initiated $82 +1.9% $80.49

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BAX receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-30 C C+
2026-04-30 C+ C
2026-02-26 C C+
2026-02-18 C+ C
2026-02-17 C C+
2026-02-17 C- C
2026-02-13 D+ C-
2026-02-13 C D+
2026-02-12 C- C
2026-02-12 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

34 Grade D
Profitability
11
Balance Sheet
33
Earnings Quality
45
Growth
37
Value
57
Momentum
38
Safety
50
Cash Flow
47
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BAX scores highest in Value (57/100) and lowest in Profitability (11/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.09
Grey Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.05
Unlikely Manipulator
Ohlson O-Score
-6.61
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
B+
Score: 32.3/100
Trend: Improving
Earnings Quality
OCF/NI: -1.14x
Accruals: -10.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BAX scores 2.09, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BAX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BAX's score of -3.05 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BAX's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BAX receives an estimated rating of B+ (score: 32.3/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-9.00x
PEG
0.13x
P/S
0.88x
P/B
1.63x
P/FCF
12.12x
P/OCF
6.92x
EV/EBITDA
22.43x
EV/Revenue
1.47x
EV/EBIT
-73.52x
EV/FCF
23.37x
Earnings Yield
-12.69%
FCF Yield
8.25%
Shareholder Yield
3.07%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BAX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.161
NI / EBT
×
Interest Burden
2.238
EBT / EBIT
×
EBIT Margin
-0.020
EBIT / Rev
×
Asset Turnover
0.494
Rev / Assets
×
Equity Multiplier
3.501
Assets / Equity
=
ROE
-16.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BAX's ROE of -16.8% is driven by financial leverage (equity multiplier: 3.50x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 2.16 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$19.18
Median 1Y
$15.16
5th Pctile
$8.58
95th Pctile
$26.79
Ann. Volatility
33.0%
Analyst Target
$27.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joel Grade
Former Executive Vice President and CFO
$827,825 $5,809,671 $8,209,568
José E. Almeida
Former Chair of the Board, President and CEO
$660,420 $— $7,666,044
Reazur Rasul Group
tive Vice President and Group President, Healthcare Systems & Technologies
$800,000 $2,953,421 $5,246,214
Alok Sonig Group
r Executive Vice President and Group President, Pharmaceuticals
$779,747 $3,375,371 $5,239,273

CEO Pay Ratio

99:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,666,044
Avg Employee Cost (SGA/emp): $77,067
Employees: 37,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
37,500
-1.3% YoY
Revenue / Employee
$299,840
Rev: $11,244,000,000
Profit / Employee
$-25,520
NI: $-957,000,000
SGA / Employee
$77,067
Avg labor cost proxy
R&D / Employee
$13,813
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 13.5% 14.7% 14.5% 11.9% 11.4% -26.7% -32.6% -33.0% -38.3% 34.8% 37.3% 37.2% 34.8% 1.5% -8.4% -7.3% -2.0% -4.4% -14.6% -16.8% -16.77%
ROA 5.9% 6.4% 4.8% 3.9% 3.8% -8.9% -7.9% -8.0% -9.2% 8.4% 9.4% 9.4% 8.8% 0.4% -2.4% -2.1% -0.6% -1.3% -4.2% -4.8% -4.79%
ROIC 11.9% 12.8% 6.1% 5.3% 4.9% -6.7% -7.8% -7.9% -8.9% 0.7% -2.0% -1.5% 1.9% 2.0% 0.1% -0.2% -0.1% -0.1% -1.7% -1.7% -1.67%
ROCE 9.1% 9.4% 5.7% 5.0% 4.6% -7.1% -8.9% -9.1% -10.6% 2.7% 3.0% 3.0% 4.2% 4.1% 0.6% 0.2% 0.2% 0.3% -1.3% -1.3% -1.33%
Gross Margin 39.8% 40.9% 40.0% 36.4% 38.1% 29.0% 37.6% 36.3% 30.0% 40.6% 37.9% 38.6% 38.3% 38.3% 34.8% 32.8% 40.2% 33.5% 19.4% 33.0% 32.99%
Operating Margin 13.7% 15.9% 10.9% 4.4% 7.3% -79.8% 9.1% 3.7% -0.5% 6.9% 8.5% 4.6% 6.6% 5.7% -15.8% 2.2% 6.8% 6.1% -24.5% 2.4% 2.44%
Net Margin 9.6% 13.9% 6.8% 1.9% 7.0% -81.4% 4.7% 1.3% -3.8% 96.5% 6.3% 1.5% -11.7% 5.2% -18.6% 4.8% 3.2% -1.6% -37.9% -0.6% -0.56%
EBITDA Margin 21.0% 22.0% 17.2% 15.2% 18.2% -72.2% 17.6% 12.9% 7.1% 11.2% 17.5% 16.9% 16.6% 11.1% -6.4% 12.4% 16.4% 15.0% -15.0% 11.2% 11.22%
FCF Margin 11.1% 12.0% 11.6% 9.9% 8.3% 5.5% 3.9% 5.6% 5.9% 8.0% 8.7% 7.4% 5.8% 4.7% 5.3% 1.8% 3.1% 2.1% 2.9% 6.3% 6.31%
OCF Margin 17.0% 18.0% 17.4% 15.2% 13.2% 10.2% 8.2% 10.1% 10.6% 11.9% 12.6% 11.1% 10.1% 9.0% 9.6% 6.2% 7.0% 6.8% 7.5% 11.1% 11.05%
ROE 3Y Avg snapshot only 1.86%
ROE 5Y Avg snapshot only -4.99%
ROA 3Y Avg snapshot only 0.57%
ROIC 3Y Avg snapshot only 3.91%
ROIC Economic snapshot only -1.49%
Cash ROA snapshot only 6.24%
Cash ROIC snapshot only 8.83%
CROIC snapshot only 5.04%
NOPAT Margin snapshot only -2.09%
Pretax Margin snapshot only -4.49%
R&D / Revenue snapshot only 4.57%
SGA / Revenue snapshot only 25.49%
SBC / Revenue snapshot only 1.03%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 33.09 30.44 30.89 34.14 29.62 -10.54 -9.85 -7.81 -7.60 6.99 7.05 7.91 6.68 175.88 -22.51 -31.01 -99.68 -34.31 -10.26 -7.88 -8.996
P/S Ratio 3.04 2.97 3.10 2.66 2.13 1.74 1.62 1.32 1.47 1.32 1.37 1.65 1.42 1.61 1.37 1.61 1.42 1.06 0.87 0.76 0.875
P/B Ratio 4.27 4.25 4.37 3.98 3.30 2.76 4.11 3.29 3.72 3.11 2.23 2.49 1.97 2.26 2.10 2.49 2.22 1.68 1.60 1.41 1.635
P/FCF 27.37 24.70 26.82 26.91 25.84 31.62 41.83 23.54 25.01 16.63 15.70 22.44 24.62 34.60 26.13 90.91 46.40 50.86 30.41 12.12 12.118
P/OCF 17.85 16.49 17.85 17.58 16.19 17.09 19.79 12.96 13.91 11.09 10.84 14.86 14.09 17.89 14.33 26.19 20.20 15.62 11.62 6.92 6.916
EV/EBITDA 16.82 16.47 21.38 20.33 17.88 -51.67 -55.96 -42.67 -30.87 19.85 17.61 19.33 15.00 16.27 26.53 32.42 29.82 22.55 23.32 22.43 22.431
EV/Revenue 3.29 3.21 4.30 3.80 3.23 2.80 2.67 2.38 2.53 2.45 2.17 2.52 2.36 2.55 2.47 2.70 2.49 2.12 1.59 1.47 1.474
EV/EBIT 26.32 25.45 32.69 34.83 33.31 -19.42 -18.85 -16.26 -14.89 52.60 46.12 48.99 29.82 33.55 220.94 605.16 848.00 458.50 -83.07 -73.52 -73.520
EV/FCF 29.65 26.76 37.20 38.36 39.09 51.01 68.85 42.51 42.87 30.84 24.96 34.25 41.04 54.70 47.03 152.08 81.49 101.67 55.29 23.37 23.374
Earnings Yield 3.0% 3.3% 3.2% 2.9% 3.4% -9.5% -10.2% -12.8% -13.2% 14.3% 14.2% 12.6% 15.0% 0.6% -4.4% -3.2% -1.0% -2.9% -9.7% -12.7% -12.69%
FCF Yield 3.7% 4.0% 3.7% 3.7% 3.9% 3.2% 2.4% 4.2% 4.0% 6.0% 6.4% 4.5% 4.1% 2.9% 3.8% 1.1% 2.2% 2.0% 3.3% 8.3% 8.25%
PEG Ratio snapshot only 0.130
EV/OCF snapshot only 13.341
EV/Gross Profit snapshot only 4.702
Shareholder Yield snapshot only 3.07%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.52 2.52 2.09 2.09 2.09 2.09 1.69 1.69 1.69 1.69 1.48 1.48 1.48 1.48 1.36 1.36 1.36 1.36 2.31 2.31 2.314
Quick Ratio 1.95 1.95 1.52 1.52 1.52 1.52 1.12 1.12 1.12 1.12 1.18 1.18 1.18 1.18 1.05 1.05 1.05 1.05 1.56 1.56 1.562
Debt/Equity 0.78 0.78 2.02 2.02 2.02 2.02 2.95 2.95 2.95 2.95 1.68 1.68 1.68 1.68 1.93 1.93 1.93 1.93 1.63 1.63 1.632
Net Debt/Equity 0.35 0.35 1.69 1.69 1.69 1.69 2.65 2.65 2.65 2.65 1.31 1.31 1.31 1.31 1.68 1.68 1.68 1.68 1.31 1.31 1.311
Debt/Assets 0.34 0.34 0.55 0.55 0.55 0.55 0.61 0.61 0.61 0.61 0.50 0.50 0.50 0.50 0.52 0.52 0.52 0.52 0.50 0.50 0.499
Debt/EBITDA 2.85 2.80 7.12 7.24 7.23 -23.41 -24.40 -21.16 -14.29 10.16 8.36 8.53 7.67 7.65 13.57 15.01 14.78 12.97 13.06 13.44 13.445
Net Debt/EBITDA 1.29 1.26 5.97 6.07 6.06 -19.64 -21.96 -19.05 -12.86 9.15 6.53 6.67 6.00 5.98 11.79 13.04 12.84 11.27 10.49 10.80 10.802
Interest Coverage 9.71 9.31 8.17 5.75 4.35 -5.65 -5.04 -4.70 -5.06 1.23 1.26 1.34 2.01 2.11 0.29 0.12 0.09 0.16 -0.74 -0.83 -0.825
Equity Multiplier 2.30 2.30 3.69 3.69 3.69 3.69 4.85 4.85 4.85 4.85 3.37 3.37 3.37 3.37 3.70 3.70 3.70 3.70 3.27 3.27 3.272
Cash Ratio snapshot only 0.662
Debt Service Coverage snapshot only 2.705
Cash to Debt snapshot only 0.197
FCF to Debt snapshot only 0.071
Defensive Interval snapshot only 369.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.64 0.65 0.48 0.51 0.52 0.54 0.48 0.47 0.48 0.44 0.48 0.45 0.41 0.42 0.39 0.40 0.40 0.41 0.49 0.49 0.494
Inventory Turnover 4.17 4.24 3.52 3.77 3.93 4.24 3.73 3.68 3.83 3.43 3.82 3.52 3.11 3.16 3.36 3.47 3.48 3.59 3.61 3.63 3.633
Receivables Turnover 6.25 6.38 5.52 5.84 6.06 6.22 5.69 5.62 5.66 5.27 6.39 5.91 5.44 5.49 6.26 6.34 6.41 6.49 6.23 6.27 6.270
Payables Turnover 7.68 7.81 6.71 7.20 7.51 8.09 8.12 8.02 8.34 7.47 8.83 8.12 7.18 7.30 7.20 7.45 7.47 7.70 7.85 7.90 7.901
DSO 58 57 66 62 60 59 64 65 64 69 57 62 67 67 58 58 57 56 59 58 58.2 days
DIO 88 86 104 97 93 86 98 99 95 106 95 104 117 115 109 105 105 102 101 100 100.5 days
DPO 48 47 54 51 49 45 45 46 44 49 41 45 51 50 51 49 49 47 46 46 46.2 days
Cash Conversion Cycle 99 97 116 109 104 100 117 119 116 127 111 121 134 132 116 114 113 110 113 112 112.5 days
Fixed Asset Turnover snapshot only 3.553
Operating Cycle snapshot only 158.7 days
Cash Velocity snapshot only 5.758
Capital Intensity snapshot only 1.772
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 6.9% 8.0% 9.5% 14.6% 15.1% 15.8% 15.7% 7.8% 4.8% -5.0% -7.4% -13.2% -20.7% -14.1% -22.4% -15.1% -6.7% -6.3% 5.7% 5.1% 5.10%
Net Income 21.2% 33.3% 16.5% -1.0% -9.7% -3.0% -2.9% -3.3% -3.8% 2.1% 2.1% 2.1% 1.9% -95.8% -1.2% -1.2% -1.1% -4.2% -47.5% -96.1% -96.07%
EPS 23.1% 36.4% 18.6% -0.6% -9.6% -3.0% -2.9% -3.3% -3.8% 2.1% 2.1% 2.1% 1.9% -95.9% -1.2% -1.2% -1.1% -4.1% -46.3% -95.7% -95.69%
FCF -9.9% 13.2% 27.6% 6.0% -14.4% -47.1% -61.3% -39.1% -25.2% 37.6% 1.1% 14.5% -22.5% -49.6% -53.1% -79.6% -50.4% -58.1% -42.2% 2.7% 2.74%
EBITDA 28.4% 33.6% 13.4% 11.7% 6.2% -1.3% -1.3% -1.3% -1.5% 3.2% 3.4% 3.0% 2.5% 9.0% -41.3% -45.9% -50.5% -43.8% -22.7% -17.0% -16.96%
Op. Income -5.0% -0.7% 5.8% -7.1% -21.7% -2.2% -2.2% -2.4% -2.8% 1.3% 1.3% 1.3% 1.3% 20.8% -97.7% -1.1% -1.0% -1.0% -22.9% -6.0% -5.95%
OCF Growth snapshot only 88.69%
Asset Growth snapshot only -22.21%
Equity Growth snapshot only -11.99%
Debt Growth snapshot only -25.62%
Shares Change snapshot only 0.19%
Dividend Growth snapshot only -49.81%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 3.5% 4.0% 4.8% 6.9% 8.2% 8.9% 9.2% 8.2% 8.9% 5.9% 5.5% 2.4% -1.5% -1.9% -5.9% -7.4% -8.1% -8.6% -8.7% -8.1% -8.14%
Revenue 5Y 3.9% 4.2% 4.7% 5.7% 6.4% 6.7% 7.0% 6.3% 6.0% 4.4% 4.3% 2.7% 1.1% 1.1% -1.3% -1.3% -0.9% -0.9% -0.7% -0.9% -0.86%
EPS 3Y 9.7% 3.6% -5.2% -11.3% -12.1% 42.7% 34.9% 35.5% 30.2% -55.5%
EPS 5Y -24.0% -23.1% -22.4% -9.2% 4.0% 18.8% 12.0% 11.8% 10.6% -39.7%
Net Income 3Y 7.1% 1.0% -7.0% -12.0% -12.7% 41.7% 34.1% 35.4% 30.3% -55.4%
Net Income 5Y -25.2% -24.4% -23.7% -10.7% 2.1% 17.1% 10.7% 11.3% 10.2% -39.9%
EBITDA 3Y 1.4% 0.6% 0.6% 0.7% 1.8% -2.4% -9.4% -9.9% -8.3% -8.8% -27.2% -29.2% -28.9%
EBITDA 5Y -15.7% -15.8% -15.1% -2.2% 5.9% -6.6% -7.8% -7.8% -5.2% -6.0% -11.9% -13.7% -13.3% -10.6% -19.5% -20.0% -19.97%
Gross Profit 3Y 0.8% 1.0% 2.2% 3.8% 5.4% 3.6% 3.2% 2.1% 1.1% 1.5% 2.3% 0.2% -1.7% -2.8% -7.9% -9.9% -9.9% -9.0% -12.4% -11.7% -11.69%
Gross Profit 5Y 3.3% 3.7% 4.4% 4.8% 4.6% 3.2% 3.2% 2.6% 1.0% 0.7% 0.6% -0.6% -0.6% -0.7% -3.5% -4.3% -3.4% -3.6% -5.2% -4.9% -4.93%
Op. Income 3Y 6.5% 5.4% 2.3% -1.4% -4.4% -28.3% -27.3% -27.6% -22.0% -23.4% -79.8%
Op. Income 5Y 26.3% 22.8% 18.8% 10.8% 2.5% -15.3% -17.2% -17.1% -11.9% -13.8% -62.0%
FCF 3Y 1.2% 9.3% 1.9% 8.8% 2.0% -15.5% -25.9% -19.6% -16.7% -6.2% 0.9% -9.6% -20.8% -28.4% -27.7% -47.8% -34.0% -33.8% -17.4% -4.4% -4.35%
FCF 5Y 19.8% 10.9% 9.6% -2.4% -2.5% -11.1% -13.8% -10.6% -7.9% -1.0% -3.1% -2.1% -9.3% -16.0% -16.9% -34.4% -26.0% -29.5% -22.5% -10.8% -10.81%
OCF 3Y 1.7% 7.1% 2.5% 5.6% 1.2% -10.3% -16.8% -13.0% -10.5% -6.3% -2.6% -10.6% -17.3% -22.0% -22.9% -31.4% -25.5% -20.0% -11.3% -5.5% -5.49%
OCF 5Y 8.4% 6.1% 6.1% -1.2% -1.2% -6.4% -8.0% -6.7% -4.6% -2.2% -3.5% -4.2% -8.0% -12.2% -13.5% -21.7% -18.9% -17.7% -14.7% -8.7% -8.71%
Assets 3Y 5.4% 5.4% 28.7% 28.7% 28.7% 28.7% 15.8% 15.8% 15.8% 15.8% 12.2% 12.2% 12.2% 12.2% -8.4% -8.4% -8.4% -8.4% -10.8% -10.8% -10.83%
Assets 5Y -0.9% -0.9% 16.6% 16.6% 16.6% 16.6% 10.6% 10.6% 10.6% 10.6% 12.5% 12.5% 12.5% 12.5% 7.2% 7.2% 7.2% 7.2% 0.0% 0.0% 0.04%
Equity 3Y -1.6% -1.6% 5.0% 5.0% 5.0% 5.0% -9.5% -9.5% -9.5% -9.5% -1.1% -1.1% -1.1% -1.1% -8.5% -8.5% -8.5% -8.5% 1.7% 1.7% 1.66%
Book Value 3Y 0.8% 0.9% 7.1% 5.9% 5.7% 6.1% -9.0% -9.0% -8.9% -8.9% -0.5% -1.0% -1.2% -1.5% -8.6% -8.8% -8.8% -9.1% 1.2% 1.1% 1.13%
Dividend 3Y 6.2% 6.4% 5.9% 4.7% 4.8% 4.3% 3.2% 2.6% 2.0% 1.8% 1.3% 0.5% 0.2% -0.1% 0.0% -3.7% -7.7% -12.1% -16.5% -20.9% -20.94%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.95 0.94 0.93 0.87 0.85 0.84 0.84 0.88 0.87 0.80 0.76 0.51 0.20 0.15 0.00 0.01 0.03 0.06 0.10 0.15 0.146
Earnings Stability 0.38 0.42 0.36 0.28 0.01 0.41 0.36 0.42 0.44 0.02 0.02 0.02 0.04 0.02 0.05 0.04 0.02 0.02 0.10 0.10 0.095
Margin Stability 0.97 0.97 0.96 0.96 0.96 0.94 0.93 0.93 0.91 0.92 0.92 0.92 0.92 0.93 0.93 0.93 0.92 0.94 0.92 0.93 0.925
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.87 0.93 1.00 0.96 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness 0.81 0.71 0.85 0.99 0.90 0.00
ROE Trend -0.03 -0.01 0.01 -0.01 -0.01 -0.39 -0.55 -0.54 -0.61 0.51 0.45 0.47 0.48 -0.08 -0.04 -0.03 0.07 -0.28 -0.27 -0.30 -0.297
Gross Margin Trend -0.03 -0.02 -0.01 -0.01 -0.01 -0.04 -0.04 -0.04 -0.06 -0.02 -0.02 -0.01 0.03 0.02 0.02 0.00 0.01 -0.02 -0.05 -0.05 -0.048
FCF Margin Trend -0.00 0.00 0.00 -0.02 -0.04 -0.06 -0.07 -0.05 -0.04 -0.01 0.01 -0.00 -0.01 -0.02 -0.01 -0.05 -0.03 -0.04 -0.04 0.02 0.017
Sustainable Growth Rate 7.5% 8.4% 8.5% 5.8% 5.1% 26.9% 29.1% 29.0% 26.5% -6.8%
Internal Growth Rate 3.4% 3.8% 2.9% 1.9% 1.7% 6.9% 7.9% 7.9% 7.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.85 1.85 1.73 1.94 1.83 -0.62 -0.50 -0.60 -0.55 0.63 0.65 0.53 0.47 9.83 -1.57 -1.18 -4.94 -2.20 -0.88 -1.14 -1.139
FCF/OCF 0.65 0.67 0.67 0.65 0.63 0.54 0.47 0.55 0.56 0.67 0.69 0.66 0.57 0.52 0.55 0.29 0.44 0.31 0.38 0.57 0.571
FCF/Net Income snapshot only -0.650
OCF/EBITDA snapshot only 1.681
CapEx/Revenue 5.9% 6.0% 5.8% 5.3% 4.9% 4.7% 4.3% 4.6% 4.7% 4.0% 3.9% 3.8% 4.3% 4.4% 4.3% 4.4% 4.0% 4.7% 4.6% 4.7% 4.74%
CapEx/Depreciation snapshot only 0.553
Accruals Ratio -0.05 -0.05 -0.04 -0.04 -0.03 -0.14 -0.12 -0.13 -0.14 0.03 0.03 0.04 0.05 -0.03 -0.06 -0.05 -0.03 -0.04 -0.08 -0.10 -0.102
Sloan Accruals snapshot only 0.026
Cash Flow Adequacy snapshot only 1.558
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 1.3% 1.4% 1.3% 1.5% 1.9% 2.3% 2.4% 3.0% 2.7% 3.2% 3.1% 2.8% 3.6% 3.1% 4.0% 3.1% 3.0% 3.5% 3.5% 3.1% 1.88%
Dividend/Share $0.98 $1.02 $1.05 $1.07 $1.11 $1.12 $1.13 $1.14 $1.15 $1.15 $1.16 $1.15 $1.15 $1.15 $1.16 $1.03 $0.91 $0.79 $0.68 $0.52 $0.36
Payout Ratio 44.6% 42.4% 41.3% 51.6% 55.6% 22.6% 22.1% 22.2% 23.8% 5.5%
FCF Payout Ratio 36.9% 34.4% 35.8% 40.6% 48.5% 71.6% 1.0% 71.0% 67.4% 53.7% 49.2% 62.8% 87.6% 1.1% 1.1% 2.8% 1.4% 1.8% 1.1% 37.3% 37.25%
Total Payout Ratio 1.4% 1.3% 88.0% 84.4% 59.1% 22.6% 22.1% 22.2% 23.8% 5.5%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0
Chowder Number 0.13 0.13 0.13 0.13 0.15 0.12 0.11 0.09 0.07 0.06 0.05 0.04 0.04 0.04 0.05 -0.07 -0.17 -0.27 -0.37 -0.47 -0.467
Buyback Yield 2.9% 3.0% 1.5% 1.0% 0.1% 0.1% 0.1% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 2.9% 3.0% 1.5% 1.0% 0.1% 0.1% 0.1% 0.2% 0.1% -0.2% -0.2% -0.4% -0.6% -0.4% -0.4% -0.1% -0.1% -0.1% -0.1% -0.3% -0.25%
Total Shareholder Return 4.2% 4.4% 2.8% 2.5% 2.0% 2.4% 2.5% 3.2% 2.8% 3.1% 2.9% 2.4% 3.0% 2.7% 3.6% 2.9% 3.0% 3.4% 3.4% 2.8% 2.82%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.82 0.86 0.87 0.87 0.97 0.97 0.97 0.95 0.95 21.78 19.97 16.05 5.32 0.23 2.25 1.66 0.48 1.26 1.90 2.16 2.161
Interest Burden (EBT/EBIT) 0.90 0.89 0.88 0.83 0.77 1.18 1.20 1.21 1.20 0.19 0.21 0.25 0.50 0.53 -2.43 -7.04 -10.06 -5.29 2.35 2.24 2.238
EBIT Margin 0.13 0.13 0.13 0.11 0.10 -0.14 -0.14 -0.15 -0.17 0.05 0.05 0.05 0.08 0.08 0.01 0.00 0.00 0.00 -0.02 -0.02 -0.020
Asset Turnover 0.64 0.65 0.48 0.51 0.52 0.54 0.48 0.47 0.48 0.44 0.48 0.45 0.41 0.42 0.39 0.40 0.40 0.41 0.49 0.49 0.494
Equity Multiplier 2.31 2.31 3.01 3.01 3.01 3.01 4.15 4.15 4.15 4.15 3.97 3.97 3.97 3.97 3.52 3.52 3.52 3.52 3.50 3.50 3.501
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $2.20 $2.40 $2.53 $2.08 $1.99 $-4.71 $-4.80 $-4.85 $-5.64 $5.11 $5.24 $5.19 $4.85 $0.21 $-1.27 $-1.09 $-0.30 $-0.66 $-1.86 $-2.13 $-2.13
Book Value/Share $17.07 $17.17 $17.90 $17.83 $17.87 $18.01 $11.50 $11.50 $11.53 $11.50 $16.57 $16.47 $16.47 $16.41 $13.65 $13.55 $13.55 $13.55 $11.92 $11.90 $11.68
Tangible Book/Share $7.47 $7.51 $-16.87 $-16.80 $-16.83 $-16.97 $-14.62 $-14.62 $-14.65 $-14.62 $-6.53 $-6.49 $-6.49 $-6.46 $-6.93 $-6.88 $-6.88 $-6.88 $-6.17 $-6.15 $-6.15
Revenue/Share $23.96 $24.61 $25.21 $26.61 $27.64 $28.62 $29.19 $28.80 $29.08 $27.03 $27.03 $24.86 $22.88 $22.98 $20.85 $20.96 $21.18 $21.45 $21.88 $21.98 $21.98
FCF/Share $2.66 $2.96 $2.92 $2.63 $2.28 $1.57 $1.13 $1.61 $1.71 $2.15 $2.35 $1.83 $1.32 $1.07 $1.10 $0.37 $0.65 $0.45 $0.63 $1.39 $1.39
OCF/Share $4.08 $4.43 $4.38 $4.03 $3.64 $2.91 $2.39 $2.92 $3.08 $3.22 $3.40 $2.76 $2.30 $2.07 $2.00 $1.29 $1.49 $1.46 $1.64 $2.43 $2.43
Cash/Share $7.33 $7.37 $5.82 $5.80 $5.81 $5.86 $3.39 $3.39 $3.40 $3.39 $6.07 $6.04 $6.04 $6.01 $3.46 $3.43 $3.43 $3.43 $3.82 $3.82 $3.92
EBITDA/Share $4.69 $4.80 $5.07 $4.97 $4.99 $-1.55 $-1.39 $-1.60 $-2.38 $3.34 $3.33 $3.25 $3.61 $3.61 $1.94 $1.74 $1.77 $2.02 $1.49 $1.44 $1.44
Debt/Share $13.37 $13.45 $36.11 $35.97 $36.04 $36.33 $33.93 $33.93 $34.00 $33.93 $27.84 $27.67 $27.67 $27.56 $26.37 $26.17 $26.17 $26.17 $19.46 $19.42 $19.42
Net Debt/Share $6.04 $6.08 $30.29 $30.17 $30.23 $30.47 $30.54 $30.54 $30.60 $30.54 $21.77 $21.64 $21.64 $21.55 $22.91 $22.73 $22.73 $22.73 $15.64 $15.61 $15.61
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.089
Altman Z-Prime snapshot only 4.079
Piotroski F-Score 9 9 6 5 5 4 4 4 4 5 5 4 4 3 2 2 3 2 4 5 5
Beneish M-Score -2.60 -2.61 -1.97 -1.92 -1.91 -2.13 -3.14 -3.24 -3.17 -2.51 -2.63 -2.60 -2.68 -2.88 -2.71 -2.66 -2.72 -2.65 -2.48 -3.05 -3.048
Ohlson O-Score snapshot only -6.605
Net-Net WC snapshot only $-13.75
EVA snapshot only $-1652810000.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B+
Credit Score 77.71 77.91 51.35 49.68 47.63 33.95 31.02 30.94 32.19 33.87 34.45 34.41 38.64 38.79 30.15 30.57 29.88 23.92 31.23 32.26 32.262
Credit Grade snapshot only 14
Credit Trend snapshot only 1.689
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 15
Sector Credit Rank snapshot only 24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms